Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Senthil Lingaratnam

Director of Pharmacy

Peter MacCallum Cancer Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Articles (13)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (11)

Marc Pellegrini

Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Karin Thursky

Associate Director of Health Services Research and Implementation Science

University of Melbourne

AUSTRALIA

View details

Marliese Alexander

Deputy Director of Pharmacy (Quality and Research)

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Paul James

Head of Adult Genetics

The Royal Melbourne Hospital Royal Park Campus

AUSTRALIA

View details

Michelle Yong

University of Melbourne

AUSTRALIA

View details

Jeff Szer

Stream Lead

AUSTRALIA

View details

Joseph A. Nicolazzo

MONASH UNIVERSITY

AUSTRALIA

View details

Carl Kirkpatrick

Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Julie Simpson

University of Melbourne

AUSTRALIA

View details

Maarten IJzerman

Full professor

Erasmus University Rotterdam

NETHERLANDS

View details

Chiao Xin Lim

Senior lecturer

RMIT University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Senthil Lingaratnam

Research Interests

Explore related searches

Articles (13)

Antimicrobial stewardship prospective audit and feedback improves uptake of intravenous to oral antimicrobial switch in oncology inpatients: a cohort study

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial

Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers

An Australasian survey of clinical practices in management of neutropenic fever in adult cancer patients 2023

Usability testing of an online, evidence-based pharmacogenomics education program for pharmacists working in cancer care

A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer

Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review

Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial

Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists

Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis

Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer

Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey

Collaborators (11)

Marc Pellegrini

Karin Thursky

Marliese Alexander

Paul James

Michelle Yong

Jeff Szer

Joseph A. Nicolazzo

Carl Kirkpatrick

Julie Simpson

Maarten IJzerman

Chiao Xin Lim

Make your next move.